Peptides DB
Research-centric peptide and protocol reference hub

Research library

Every indexed study on every peptide in the database, with a machine summary and the numbers that matter pulled out. Filter on the left; the register updates as you go.

2542studies indexed1157with human data159registered trials2229carry a numeric findingLibrarian added 0 studies today
Showing 1 studiesSortNewest indexed ▾
A
grade
A Phase 2, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Acmopatide (CT-868), a Fully Biased GLP-1/GIP Receptor Agonist, in Adults With Type 1 Diabetes and Overweight or Obesity.
Acmopatide · Diabetes care · 2026 · RCT · Phase 2High-impact journal
Acmopatide showed statistically significant improvements in HbA1c and weight loss in adults with type 1 diabetes, but the clinical significance of these changes may be limited.
HbA1c least squares mean change from baseline -0.4 to -0.6% vs. -0.3% with placebo, P = 0.020.
Showing 1 of 1